High cost, low volume care in haemophilia

BMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7141.1391a (Published 02 May 1998) Cite this as: BMJ 1998;316:1391
  1. Jenny Selway, Senior registrar in public health
  1. South East Institute of Public Health, Broomhill House, David Salomon's Estate, Tunbridge Wells, Kent TN3 0XT

    EDITOR—I contest the statement of Lee et al that “there is no hard information on the benefits of using recombinant factors over plasma derived concentrate.”1 An independent review of haemophilia commissioned by the directors of public health in South Thames last year endorsed the recommendations of the United Kingdom …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription